Roche Eesti Osaühing
In the registerRegistry code: 11124024
Roche Eesti Osaühing: 2025 revenue 48,446,000 €, net profit 1,867,000 € (Company only). 29 employees, 2025 annual average (Company only). Äriregister. Snapshot: 10.11.2026.
- Current tax-debt statusNot listedEMTA. Observation: 09.11.2026Not on the EMTA public tax-debt list (≥100 €) as of 09.11.2026.
- Report 2025FiledÄriregisterCompany only
- NoticesNo warning noticesAmetlikud Teadaanded. Observation: 09.11.2026
- Revenue 202548,446,000 ۀriregisterCompany only
- Employees 202529Äriregisterannual average; Company only
Place in the peer group
EMTAK 74991, Harju County, 2025
Revenue 2025, company only, n = 1,218 filed reports
marker = company, band = p25–p75, axis = percentile 0–100
| Metric | Company | Median | Percentile |
|---|---|---|---|
| Revenue | 48,446,000 € | 16,167 € | p100 (n = 1,218) |
| Net profit | 1,867,000 € | 698 € | p100 (n = 1,436) |
| Equity | 13,561,000 € | 12,292 € | p100 (n = 1,437) |
| Employees | 29 | 0 | p99 (n = 1,537) |
Each percentile is computed separately, so n differs; hidden below 5 companies; medians and quartiles in whole euros (rounded). Source: Business Register (annual reports), snapshot 10.11.2026.
Not an official extract; no credit rating is provided.
Register details and contacts
- Registered name
- Roche Eesti Osaühing
- Registry code
- 11124024
- Status
- in the register (R)
- Legal form
- Private limited company
- Registered
- 15.04.2005
- Share capital
- 127,823 €
- VAT number
- EE100987243
- Address
- Harju County · Tallinn, Lasnamäe linnaosa, Lõõtsa tn 2a
- Website
- roche.ee
- Phone
- +372 6177380
Source: Business Register (open data), CC BY 4.0
Names of current board members load in the interactive view.
Report coverage
Annual reports found in our data as of 2026-11-10
Cohort: R-status OÜs registered before 2023, with a 31 December fiscal year end. Years 2024 and 2025 are fixed, independent of the financial benchmark year. Sector and county use current principal company details.
Absence from our data is not evidence of non-filing. Each company counts once per year, including zero or missing revenue. Completeness of national coverage is unknown.
Source extract cutoff: 2026-10-31
↔ Scroll horizontally to see all columns.
| Fiscal year | Data status |
|---|---|
| 2024 | Found in data |
| 2025 | Found in data |
Roche Eesti Osaühing is a private limited company. In 2025, revenue grew 10.3 % to 48,446,000 €, profit stayed at 1,867,000 €. The main activity is NACE class: All other professional, scientific and technical activities n.e.c. (74991). The company is located in Harju County. Registered 15.04.2005. Share capital is 127,823 €. 2025 annual-report figures (Company only): annual average employees 29. Taxes for III quarter of 2026 were 1,638,799 €. Not on the EMTA public tax-debt list (≥100 €) as of 09.11.2026. EMTA. Snapshot: 10.11.2026. There are 1 state aid and grant records. There are 95 single-winner procurement wins (2023–2026); recorded contract/framework ceiling value 110,623,039.87 €, not actual payments.
What are the company indicators (2025)?
Roche Eesti Osaühing: revenue 48,446,000 € (period: 2025; company only; source: Äriregister; snapshot: 10.11.2026).
Annual-report figures: Company only Tax data refers to this legal entity.
Peer group: 74991 · Harju County · 2025 · n = 1,218
↔ Scroll horizontally to see all columns.
| Metric | Value | Δ | Position | Period and basis | Source | As of | Comparison and sources |
|---|---|---|---|---|---|---|---|
| Revenue2019 – 2025 | 48,446,000 € | +10.3 % | p100 (n = 1218) | 2025; Company only | RIK | checked 10.11.2026 | +10.3 %p100 (n = 1218)2025; Company onlyRIKchecked 10.11.2026 |
| Net profit2019 – 2025 | 1,867,000 € | 0 % | p100 (n = 1436) | 2025 · margin 3.9 % (previous year 4.2 %); Company only | RIK | checked 10.11.2026 | 0 %p100 (n = 1436)2025 · margin 3.9 % (previous year 4.2 %); Company onlyRIKchecked 10.11.2026 |
| Equity2019 – 2025 | 13,561,000 € | — | p100 (n = 1437) | 2025 · share of assets 35.8 % (previous year 46.6 %); Company only | RIK | checked 10.11.2026 | p100 (n = 1437)2025 · share of assets 35.8 % (previous year 46.6 %); Company onlyRIKchecked 10.11.2026 |
| Employees2019 – 2025 | 29 | — | p99 (n = 1537) | 2025; Company only | RIK | checked 10.11.2026 | p99 (n = 1537)2025; Company onlyRIKchecked 10.11.2026 |
| Turnover per the Tax Board2022 I – 2026 III | 12,749,834 € | — | — | 2025 IV · VAT registered; Company only | MTA | checked 10.11.2026 | 2025 IV · VAT registered; Company onlyMTAchecked 10.11.2026 |
| State taxes2022 I – 2026 III | 519,593 € | — | — | 2025 IV; Company only | MTA | checked 10.11.2026 | 2025 IV; Company onlyMTAchecked 10.11.2026 |
| Labour taxes2022 I – 2026 III | 302,405 € | — | — | 2025 IV; Company only | MTA | checked 10.11.2026 | 2025 IV; Company onlyMTAchecked 10.11.2026 |
| State aid received | 1,420 € | — | — | 1 decisions · latest 2023 | RAR | snapshot 10.11.2026 | 1 decisions · latest 2023RARsnapshot 10.11.2026 |
| Report 2025 | filed | — | — | — | RIK | checked 10.11.2026 | RIKchecked 10.11.2026 |
EMTA: state taxes are paid taxes net of refunds; labour taxes are paid income and social tax plus pension and unemployment insurance contributions.
The percentile (p) is the company rank among peers in the same activity and county in the same year. It is hidden when fewer than 5 companies qualify. Each figure shows its period and source.
Which legal entities are related to the company (snapshot 10.11.2026)?
Roche Eesti Osaühing: ownership links are between legal entities only; shared-board links show companies, not people (source: Äriregister; snapshot: 10.11.2026).
Dated register facts. No signals does not confirm the absence of liabilities.
Owners and holdings
Business Register shareholders · Natural-person owners are hidden, so the percentages may stay below 100 %.
State property contracts
Fees exclude VAT; currency is unknown. Each fee has its own period. Never sum or annualise fees. Types and statuses are source assertions; this is not a general property ownership register.
Rows on this page / total records: 0 / 0
No state property contracts in this snapshot.
Source: Äriregister · Riigi kinnisvararegister · Äriregister: Source observation date unknown · Riigi kinnisvararegister: Source observation date unknown · Source acquisition date unknown · Snapshot published: 10.11.2026 · View company sources · All sources and licences
What are the company signals (snapshot 10.11.2026)?
we count and cite; we do not gradeRoche Eesti Osaühing: Not on the EMTA public tax-debt list (≥100 €) as of 09.11.2026. EMTA. Snapshot: 10.11.2026.
↔ Scroll horizontally to see all columns.
| Metric | Value | Δ | Position | Period and basis | Source | As of | Comparison and sources |
|---|---|---|---|---|---|---|---|
| Current tax-debt status | Not on the EMTA public tax-debt list (≥100 €) as of 09.11.2026.Check directly: EMTA | — | — | — | EMTA | 09.11.2026 | EMTA09.11.2026 |
| Debt episode (history) | missing | — | — | off the list after 3 consecutive absences (EMTA ~11th/~21st swings) | EMTA | 09.11.2026 | off the list after 3 consecutive absences (EMTA ~11th/~21st swings)EMTA09.11.2026 |
| Annual reports | Report 2025 filed | — | — | — | RIK | checked 10.11.2026 | RIKchecked 10.11.2026 |
| Official notices | No bankruptcy, liquidation, restructuring or enforcement notices | — | — | 5 years | Ametlikud Teadaanded | checked 10.11.2026 | 5 yearsAmetlikud Teadaandedchecked 10.11.2026 |
| Status | Status changes: 1 | — | — | status history: 5 entries | RIK | checked 10.11.2026 | status history: 5 entriesRIKchecked 10.11.2026 |
| Composite signal (derived) | Lowview | — | — | Report lateness is not scored. Notice selection and time windows differ from those used for the score. | Ärikratt | — | Report lateness is not scored. Notice selection and time windows differ from those used for the score.Ärikratt |
| Commercial pledge | No commercial pledge | — | — | pledgee names withheld | RIK | checked 10.11.2026 | pledgee names withheldRIKchecked 10.11.2026 |
| Court decisions · sanctions · trademarks | source missing | — | — | a company-level link has not been published yet | — | — | a company-level link has not been published yet |
Composite signal components (derived, not an official score)
Score (derived) 0/100 derived
A composite signal from structured data, not an official assessment or credit rating. It describes data known at calculation time; no forecast horizon is specified.
Calculated 10.11.2026 10:15.
Methodology version: 1.3.
Stored component contributions
- Tax debt · 0 points
- Financial health · 0 points
- Board changes · 0 points
- Insolvency notices · 0 points
- Licence loss · 0 points
A stored 0 proves neither absence of events nor complete source coverage. Without detail, its cause is unknown.
The underlying record reference is unavailable. No specific event or document can be identified.
methodologyCalculated 10.11.2026 10:15. The score is not a credit rating and not a default forecast. methodology · The score is not a credit rating
Snapshot: Äriregister: 10.11.2026 19:44 · EMTA: 10.11.2026 19:44 · Ametlikud Teadaanded: 10.11.2026 19:44
What are the company financial results (2025)?
Roche Eesti Osaühing: net profit 1,867,000 € (period: 2025; company only; source: Äriregister; snapshot: 10.11.2026).
2025 · Company only: revenue 48,446,000 €, net profit 1,867,000 €.
Annual reports 2019–2025
↔ Scroll horizontally to see all columns.
| Metric | Value | Δ | Period and basis | Source | As of | Comparison and sources |
|---|---|---|---|---|---|---|
| Revenue | 48,446,000 € | +10.3 % | 2025; Company only | RIK | checked 10.11.2026 | +10.3 %2025; Company onlyRIKchecked 10.11.2026 |
| Net profit | 1,867,000 € | 0 % | 2025; Company only | RIK | checked 10.11.2026 | 0 %2025; Company onlyRIKchecked 10.11.2026 |
| Equity | 13,561,000 € | +7 % | 2025; Company only | RIK | checked 10.11.2026 | +7 %2025; Company onlyRIKchecked 10.11.2026 |
| Assets | 37,902,000 € | +39.4 % | 2025; Company only | RIK | checked 10.11.2026 | +39.4 %2025; Company onlyRIKchecked 10.11.2026 |
| Employees | 29 | 0 % | 2025; Company only | RIK | checked 10.11.2026 | 0 %2025; Company onlyRIKchecked 10.11.2026 |
| Revenue | 43,938,000 € | +17.4 % | 2024; Company only | RIK | checked 10.11.2026 | +17.4 %2024; Company onlyRIKchecked 10.11.2026 |
| Net profit | 1,867,000 € | +84.5 % | 2024; Company only | RIK | checked 10.11.2026 | +84.5 %2024; Company onlyRIKchecked 10.11.2026 |
| Equity | 12,674,000 € | +29.1 % | 2024; Company only | RIK | checked 10.11.2026 | +29.1 %2024; Company onlyRIKchecked 10.11.2026 |
| Assets | 27,188,000 € | +23.5 % | 2024; Company only | RIK | checked 10.11.2026 | +23.5 %2024; Company onlyRIKchecked 10.11.2026 |
| Employees | 29 | +3.6 % | 2024; Company only | RIK | checked 10.11.2026 | +3.6 %2024; Company onlyRIKchecked 10.11.2026 |
| Revenue | 37,435,000 € | -0.3 % | 2023; Company only | RIK | checked 10.11.2026 | -0.3 %2023; Company onlyRIKchecked 10.11.2026 |
| Net profit | 1,012,000 € | -14.1 % | 2023; Company only | RIK | checked 10.11.2026 | -14.1 %2023; Company onlyRIKchecked 10.11.2026 |
| Equity | 9,820,000 € | +11.5 % | 2023; Company only | RIK | checked 10.11.2026 | +11.5 %2023; Company onlyRIKchecked 10.11.2026 |
| Assets | 22,021,000 € | +14.3 % | 2023; Company only | RIK | checked 10.11.2026 | +14.3 %2023; Company onlyRIKchecked 10.11.2026 |
| Employees | 28 | -3.4 % | 2023; Company only | RIK | checked 10.11.2026 | -3.4 %2023; Company onlyRIKchecked 10.11.2026 |
| Revenue | 37,547,000 € | +20.8 % | 2022; Company only | RIK | checked 10.11.2026 | +20.8 %2022; Company onlyRIKchecked 10.11.2026 |
| Net profit | 1,178,000 € | +14.3 % | 2022; Company only | RIK | checked 10.11.2026 | +14.3 %2022; Company onlyRIKchecked 10.11.2026 |
| Equity | 8,808,000 € | +15.4 % | 2022; Company only | RIK | checked 10.11.2026 | +15.4 %2022; Company onlyRIKchecked 10.11.2026 |
| Assets | 19,268,000 € | +1.6 % | 2022; Company only | RIK | checked 10.11.2026 | +1.6 %2022; Company onlyRIKchecked 10.11.2026 |
| Employees | 29 | +7.4 % | 2022; Company only | RIK | checked 10.11.2026 | +7.4 %2022; Company onlyRIKchecked 10.11.2026 |
| Revenue | 31,074,000 € | +5.3 % | 2021; Company only | RIK | checked 10.11.2026 | +5.3 %2021; Company onlyRIKchecked 10.11.2026 |
| Net profit | 1,031,000 € | +25.9 % | 2021; Company only | RIK | checked 10.11.2026 | +25.9 %2021; Company onlyRIKchecked 10.11.2026 |
| Equity | 7,630,000 € | +15.6 % | 2021; Company only | RIK | checked 10.11.2026 | +15.6 %2021; Company onlyRIKchecked 10.11.2026 |
| Assets | 18,973,000 € | +7 % | 2021; Company only | RIK | checked 10.11.2026 | +7 %2021; Company onlyRIKchecked 10.11.2026 |
| Employees | 27 | +8 % | 2021; Company only | RIK | checked 10.11.2026 | +8 %2021; Company onlyRIKchecked 10.11.2026 |
| Revenue | 29,521,000 € | +14.7 % | 2020; Company only | RIK | checked 10.11.2026 | +14.7 %2020; Company onlyRIKchecked 10.11.2026 |
| Net profit | 819,000 € | +22.8 % | 2020; Company only | RIK | checked 10.11.2026 | +22.8 %2020; Company onlyRIKchecked 10.11.2026 |
| Equity | 6,599,000 € | +14.2 % | 2020; Company only | RIK | checked 10.11.2026 | +14.2 %2020; Company onlyRIKchecked 10.11.2026 |
| Assets | 17,732,000 € | +11.7 % | 2020; Company only | RIK | checked 10.11.2026 | +11.7 %2020; Company onlyRIKchecked 10.11.2026 |
| Employees | 25 | +8.7 % | 2020; Company only | RIK | checked 10.11.2026 | +8.7 %2020; Company onlyRIKchecked 10.11.2026 |
| Revenue | 25,743,000 € | — | 2019; Company only | RIK | checked 10.11.2026 | 2019; Company onlyRIKchecked 10.11.2026 |
| Net profit | 667,000 € | — | 2019; Company only | RIK | checked 10.11.2026 | 2019; Company onlyRIKchecked 10.11.2026 |
| Equity | 5,780,000 € | — | 2019; Company only | RIK | checked 10.11.2026 | 2019; Company onlyRIKchecked 10.11.2026 |
| Assets | 15,881,000 € | — | 2019; Company only | RIK | checked 10.11.2026 | 2019; Company onlyRIKchecked 10.11.2026 |
| Employees | 23 | — | 2019; Company only | RIK | checked 10.11.2026 | 2019; Company onlyRIKchecked 10.11.2026 |
Source: Äriregister · Latest available report year: 2025 (annual reporting) · Äriregister: Source observation date unknown · Source acquisition date unknown · Snapshot published: 10.11.2026 · View company sources · All sources and licences
How much tax did the company pay (2026 III)?
Roche Eesti Osaühing: state taxes 1,638,799 € (period: 2026 III; company only; source: EMTA; snapshot: 10.11.2026).
↔ Scroll horizontally to see all columns.
| Metric | Value | Δ | Position | Period and basis | Source | As of | Comparison and sources |
|---|---|---|---|---|---|---|---|
| Quarterly declared turnover (EMTA) | 22,928,752 € | — | — | 2026 III; Company only | EMTA | checked 10.11.2026 | 2026 III; Company onlyEMTAchecked 10.11.2026 |
| State taxes | 1,638,799 € | — | — | 2026 III; Company only | EMTA | checked 10.11.2026 | 2026 III; Company onlyEMTAchecked 10.11.2026 |
| Labour taxes | 290,661 € | — | — | 2026 III; Company only | EMTA | checked 10.11.2026 | 2026 III; Company onlyEMTAchecked 10.11.2026 |
| Employees (EMTA quarter, legal entity) | 36 | — | — | 2026 III; Company only | EMTA | checked 10.11.2026 | 2026 III; Company onlyEMTAchecked 10.11.2026 |
| Quarter | Quarterly declared turnover (EMTA) (€) | State taxes € | Labour taxes € | Employees (EMTA quarter, legal entity) |
|---|---|---|---|---|
| 2026 III | 22,928,752 | 1,638,799 | 290,661 | 36 |
| 2026 II | 10,945,656 | 879,357 | 706,481 | 36 |
| 2026 I | 17,830,371 | 1,105,634 | 399,739 | 39 |
| 2025 IV | 12,749,834 | 519,593 | 302,405 | 41 |
| 2025 III | 16,960,837 | 1,284,385 | 374,337 | 42 |
| 2025 II | 10,066,634 | 954,291 | 714,607 | 39 |
| 2025 I | 20,894,631 | 1,017,363 | 302,605 | 40 |
| 2024 IV | 10,924,642 | 511,203 | 276,622 | 41 |
| 2024 III | 19,994,735 | 1,013,925 | 321,168 | 42 |
| 2024 II | 15,446,918 | 1,020,573 | 544,280 | 40 |
Showing 10 / 19
Source: EMTA · Latest available tax quarter: 2026 Q3 (quarterly tax figures) · Company debt-list observation: 09.11.2026 (daily debt list) · EMTA: Debt list observed: 09.11.2026 · daily debt list · Source acquisition date unknown · Snapshot published: 10.11.2026 · View company sources · All sources and licences
What state aid has the company received (snapshot 10.11.2026)?
Roche Eesti Osaühing: displayed state aid decisions and project grants 1 (source: RAR; snapshot: 10.11.2026).
Ettevõtluse ja Innovatsiooni Sihtasutus · Koolitus VTA >> Koolitus VTA · 04.12.2023
Amount €: 1,420
Incorporated < 90 days before decision: Rule not met; ; ; state_aid:23199 | 2023-12-04 | https://rar.fin.ee/rar/providedAidsByRecipientAndMeasureReviewPage.action; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
Observed ship-register entries
Owner entry in the register, may not be current owner. Current ownership is unverified. Separate revisions are separate entries, not additional vessels. Type and use retain the source wording.
No observed entries for open ships in this snapshot.
Source: Centre of Registers and Information Systems, ship register · Licence: CC BY-SA 4.0 · RIK Laev.xml, CC BY-SA 4.0 · Registrite ja Infosüsteemide Keskus (RIK) · Data catalogue
Environmental records
Source presence and source status do not confirm permit validity. Emission sources and waste facilities are separate record types. Record counts are not an environmental footprint or pollution quantities. Location is unknown.
No environmental records in this snapshot.
Source: RTK · MTR · Keskkonnaamet · RTK: Source observation date unknown · MTR: Source observation date unknown · Keskkonnaamet: Source observation date unknown · Source acquisition date unknown · Snapshot published: 10.11.2026 · View company sources · All sources and licences
What procurement has the company won (snapshot 10.11.2026)?
Roche Eesti Osaühing: procurement wins 95 (source: Riigihangete register; snapshot: 10.11.2026).
Won a tender. The company has won a public tender, 95 wins.
Informational indicators, not accusations or proof of wrongdoing. Free CSV exports the loaded rows. Load more to include further results.
Faritsimab · 30.07.2026
Incorporated < 90 days before decision: Rule not met; ; ; e1977e32-c62f-4885-9bc6-0f39f9eb8d6f/RES-0000/11124024 | 2026-07-30 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/312678; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; e1977e32-c62f-4885-9bc6-0f39f9eb8d6f/RES-0000/11124024 | 2026-07-30 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/312678 Repeated recorded procedures: Indicator present; Distinct procedures: 3; Retained award dates: 2024-06-03 – 2026-07-30; Same corporate buyer and supplier; distinct unambiguous folder IDs across all retained records, independent of the page filters.; ; d131da27-1cb5-4a0f-b8fb-e9521a5c2e3e/e1977e32-c62f-4885-9bc6-0f39f9eb8d6f/RES-0000/TEN-0001/11124024 | 2026-07-30 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/312678; f16911d9-c398-47d2-8e41-eacca5630174/806e2fe3-f187-4bd7-96e6-42fb8268bc00/RES-0000/TEN-0001/11124024 | 2024-06-03 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/280209; f3a1b584-b8cb-447d-bda4-1adebb68e6b0/c9432e95-90a7-489c-b45e-fc1c56ddfb21/RES-0000/TEN-0001/11124024 | 2025-02-12 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/289655 On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
e1977e32-c62f-4885-9bc6-0f39f9eb8d6f/RES-0000/11124024 · 2026-07-30
ariregister:11124024 · 2005-04-15
e1977e32-c62f-4885-9bc6-0f39f9eb8d6f/RES-0000/11124024 · 2026-07-30
Mitmesugused ravimid juuni 2026 · 30.07.2026
Incorporated < 90 days before decision: Rule not met; ; ; 6d7cf606-7f48-4b37-ba1a-3ccf41c7e327/RES-0003/11124024 | 2026-07-30 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/311634; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; 6d7cf606-7f48-4b37-ba1a-3ccf41c7e327/RES-0003/11124024 | 2026-07-30 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/311634 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
6d7cf606-7f48-4b37-ba1a-3ccf41c7e327/RES-0003/11124024 · 2026-07-30
ariregister:11124024 · 2005-04-15
6d7cf606-7f48-4b37-ba1a-3ccf41c7e327/RES-0003/11124024 · 2026-07-30
Immunosupressantide ja immunostimulaatorite ostmine · 11.06.2026
Incorporated < 90 days before decision: Rule not met; ; ; 948495f6-508e-464d-a0e8-cad5babfaf43/RES-0001/11124024 | 2026-06-11 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/308199; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; 948495f6-508e-464d-a0e8-cad5babfaf43/RES-0001/11124024 | 2026-06-11 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/308199 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
948495f6-508e-464d-a0e8-cad5babfaf43/RES-0001/11124024 · 2026-06-11
ariregister:11124024 · 2005-04-15
948495f6-508e-464d-a0e8-cad5babfaf43/RES-0001/11124024 · 2026-06-11
Immunosupressantide ja immunostimulaatorite ostmine · 11.06.2026
Incorporated < 90 days before decision: Rule not met; ; ; 948495f6-508e-464d-a0e8-cad5babfaf43/RES-0000/11124024 | 2026-06-11 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/308199; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; 948495f6-508e-464d-a0e8-cad5babfaf43/RES-0000/11124024 | 2026-06-11 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/308199 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
948495f6-508e-464d-a0e8-cad5babfaf43/RES-0000/11124024 · 2026-06-11
ariregister:11124024 · 2005-04-15
948495f6-508e-464d-a0e8-cad5babfaf43/RES-0000/11124024 · 2026-06-11
Antineoplastilised ravimid · 08.04.2026
Incorporated < 90 days before decision: Rule not met; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0019/11124024 | 2026-04-08 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0019/11124024 | 2026-04-08 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0019/11124024 · 2026-04-08
ariregister:11124024 · 2005-04-15
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0019/11124024 · 2026-04-08
Antineoplastilised ravimid · 08.04.2026
Incorporated < 90 days before decision: Rule not met; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0018/11124024 | 2026-04-08 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0018/11124024 | 2026-04-08 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0018/11124024 · 2026-04-08
ariregister:11124024 · 2005-04-15
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0018/11124024 · 2026-04-08
Antineoplastilised ravimid · 08.04.2026
Incorporated < 90 days before decision: Rule not met; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0017/11124024 | 2026-04-08 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0017/11124024 | 2026-04-08 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0017/11124024 · 2026-04-08
ariregister:11124024 · 2005-04-15
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0017/11124024 · 2026-04-08
Antineoplastilised ravimid · 08.04.2026
Incorporated < 90 days before decision: Rule not met; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0011/11124024 | 2026-04-08 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0011/11124024 | 2026-04-08 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0011/11124024 · 2026-04-08
ariregister:11124024 · 2005-04-15
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0011/11124024 · 2026-04-08
Antineoplastilised ravimid · 26.03.2026
Incorporated < 90 days before decision: Rule not met; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0012/11124024 | 2026-03-26 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; a1220e39-7126-4fdd-b568-66692ca7d855/RES-0012/11124024 | 2026-03-26 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/304907 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0012/11124024 · 2026-03-26
ariregister:11124024 · 2005-04-15
a1220e39-7126-4fdd-b568-66692ca7d855/RES-0012/11124024 · 2026-03-26
Verejooksu tõkestavad ja aneemiavastased ravimid · 03.02.2026
Incorporated < 90 days before decision: Rule not met; ; ; 8587f382-a73f-4f49-8cd8-0c565fc78bb5/RES-0012/11124024 | 2026-02-03 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/300922; ariregister:11124024 | 2005-04-15 | https://ariregister.rik.ee/est/company/11124024 One tender reported: Indicator present; ; ; 8587f382-a73f-4f49-8cd8-0c565fc78bb5/RES-0012/11124024 | 2026-02-03 | https://riigihanked.riik.ee/rhr-web/#/procurement-ref/300922 Repeated recorded procedures: Unknown; ; ; On the EMTA list on the decision date: Unknown; ; ; Informational indicators, not accusations or proof of wrongdoing. Methodology and limitations: /en/info#award-context
8587f382-a73f-4f49-8cd8-0c565fc78bb5/RES-0012/11124024 · 2026-02-03
ariregister:11124024 · 2005-04-15
8587f382-a73f-4f49-8cd8-0c565fc78bb5/RES-0012/11124024 · 2026-02-03
Showing 10 · View market winners
Source: Riigihangete register · Riigihangete register: Source observation date unknown · Source acquisition date unknown · Snapshot published: 10.11.2026 · View company sources · All sources and licences
What changed in the company history (snapshot 10.11.2026)?
Roche Eesti Osaühing: the timeline shows historical events, not an assessment of current status (source: Äriregister, EMTA, Ametlikud Teadaanded, RAR; snapshot: 10.11.2026).
2026
Reports, taxes and grants (3)
- Tax Board 2026 III: turnover €22.9m, employees: 36
- Tax Board 2026 II: turnover €10.9m, employees: 36
- Tax Board 2026 I: turnover €17.8m, employees: 39
2025
Reports, taxes and grants (1)
- Tax Board 2025 IV: turnover €12.7m, employees: 41
2011
- Share capital changed: 2000000.0 EEK → €127,823
2005
- Share capital changed: 1000000.0 EEK → 2000000.0 EEK
- Entered in the business register
- Share capital changed: missing → 1000000.0 EEK
- Name changed: missing → Roche Eesti Osaühing
- Status changed: missing → in the register
Showing 10 / 26
Events: 26 · newest first · Sources: Business Register, Tax Board, RTK, Official Notices
Which sources supply the data (snapshot 10.11.2026)?
Roche Eesti Osaühing: displayed source records 9 (source: Äriregister, EMTA, RTK, MTR, Keskkonnaamet, Ametlikud Teadaanded, Riigi kinnisvararegister, Riigihangete register, RIK laevakinnistusraamat; snapshot: 10.11.2026).
↔ Scroll horizontally to see all columns.
| Block | Source | Licence | Expected cadence | Source observation | Snapshot | Checked | Official record |
|---|---|---|---|---|---|---|---|
| Business Register | Äriregister | CC BY 4.0 | nightly | Source observation date unknown | 10.11.2026 19:44 | 10.11.2026 | open ↗ |
| Taxes | EMTA | CC BY-SA 3.0 | quarterly tax figures / daily debt list | Debt list observed: 09.11.2026 · daily debt list | 10.11.2026 19:44 | 10.11.2026 | open ↗ |
| Grants | RTK | CC BY-SA 3.0 (Euroopa Liidu struktuuritoetus). RAR: AvTS § 3¹ lg 9. | missing | Source observation date unknown | 10.11.2026 19:44 | 10.11.2026 | open ↗ |
| Licences | MTR | CC BY-SA 3.0 | missing | Source observation date unknown | 10.11.2026 19:44 | 10.11.2026 | open ↗ |
| Licences | Keskkonnaamet | AvTS § 3¹ lg 9 | missing | Source observation date unknown | 10.11.2026 19:44 | 10.11.2026 | open ↗ |
| Announcements | Ametlikud Teadaanded | CC BY-SA 4.0 | nightly | Latest retained notice published: 09.11.2026 · Source observation date unknown | 10.11.2026 19:44 | 10.11.2026 | open ↗ |
| State property | Riigi kinnisvararegister | CC0 1.0 | missing | Source observation date unknown | 10.11.2026 19:44 | 10.11.2026 | open ↗ |
| Public procurement | Riigihangete register | CC BY-SA 3.0 | nightly | Source observation date unknown | 10.11.2026 19:44 | 10.11.2026 | open ↗ |
| missing | RIK laevakinnistusraamat | CC BY-SA 4.0 | missing | Source observation date unknown | missing | missing | open ↗ |
| Court decisions, trademarks, sanctions | source missing — a company-level link has not been published yet; this does not mean there are no records | ||||||
Dates and their basis
Source observation is the source’s own as-of date; the latest notice publication does not prove observation. Snapshot is the data extract publication time. Checked is the source availability check. Missing clocks are not inferred from other dates.